About the Nasal Cavity Cancer Session
Nasal cavity cancer, though rare, poses significant challenges due to its complex anatomy and late diagnosis. Current cancer research endeavors focus on several fronts. Early detection methods, such as advanced imaging techniques and biomarker identification, are being explored to improve prognosis. Treatment modalities, including surgery, radiation therapy, and chemotherapy, are undergoing refinement to enhance efficacy while minimizing side effects. Immunotherapy, a promising avenue in cancer treatment, is being investigated to harness the body's immune system to target cancer cells specifically. Additionally, genetic studies aim to unravel the molecular mechanisms underlying nasal cavity cancer, paving the way for targeted therapies. Collaborative efforts between researchers, clinicians, and pharmaceutical companies are crucial in advancing our understanding and management of this challenging disease.
Topics Covered in Nasal Cavity Cancer
Sinonasal Carcinomas
Mucosal Melanoma
Inverted Papilloma
Occupational Carcinogens
Endoscopic Resection
Orbital Preservation
Related Scientific Sessions at CIOC 2027
Why Attend the Nasal Cavity Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Nasal Cavity Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Nasal Cavity Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Nasal Cavity Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Nasal Cavity Cancer Conference 2027 — FAQs
What is the Nasal Cavity Cancer track at CIOC 2027?
The Nasal Cavity Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Nasal Cavity Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Nasal Cavity Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Nasal Cavity Cancer are all welcome — whether presenting or attending.
Can I present my research in the Nasal Cavity Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Nasal Cavity Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Nasal Cavity Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.